AGXT
AGXT (alanine--glyoxylate aminotransferase, also known as AGT, AGT1, AGXT1, PH1, SPT, TLH6, Ser-PyrAT and SPAT) is a peroxisomal aminotransferase that converts glyoxylate to glycine and so contributes to glyoxylate detoxification. Browse Assay Genie's current range of AGXT research reagents below, or read on for the biology behind the target.
AGXT is a peroxisomal aminotransferase that catalyses the transamination of glyoxylate to glycine, a reaction that contributes to the detoxification of glyoxylate. The enzyme also catalyses transamination between L-serine and pyruvate, and through this activity it contributes to gluconeogenesis from L-serine metabolism. The second activity explains the earlier name serine:pyruvate aminotransferase, and the symbols SPT, Ser-PyrAT and SPAT.
The AGXT gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family, which HGNC places in the transaminases gene group. According to the NCBI Gene summary, the gene is expressed only in the liver, and the encoded protein is localised mostly in peroxisomes, where it carries out its role in glyoxylate detoxification. Mouse and rat both have an orthologous Agxt gene, so the enzyme can be studied in standard rodent models.
Mutations in the AGXT gene have been associated with type I primary hyperoxaluria, which is the origin of the alias PH1. Some of these mutations alter the subcellular targeting of the protein, so that the enzyme is not directed correctly to the peroxisome. For this reason, researchers working on AGXT often consider enzyme localisation alongside expression and activity. The HGNC previous names also include alanine--glyoxylate and serine--pyruvate aminotransferase, reflecting the two reactions the enzyme performs.
Mutations in AGXT are associated with type I primary hyperoxaluria, making the protein a central subject in studies of this disorder.
AGXT converts glyoxylate to glycine in peroxisomes, so it is a key enzyme for studying how cells handle this reactive metabolite.
Some disease-associated AGXT mutations alter subcellular targeting, which makes the protein a useful model for peroxisomal protein localisation.
AGXT is expressed only in the liver and links L-serine metabolism to gluconeogenesis through its serine:pyruvate transamination activity.
AGXT is a peroxisomal aminotransferase that catalyses the transamination of glyoxylate to glycine, contributing to glyoxylate detoxification. It also catalyses transamination between L-serine and pyruvate, contributing to gluconeogenesis from L-serine metabolism. It belongs to the class-V pyridoxal-phosphate-dependent aminotransferase family.
AGXT is also called AGXT1, PH1, AGT, AGT1, TLH6, SPT, Ser-PyrAT and SPAT. Previous names include serine:pyruvate aminotransferase and alanine--glyoxylate and serine--pyruvate aminotransferase, which reflect its two transamination activities. The enzyme is classified as EC 2.6.1.44.
Mutations in the AGXT gene are associated with type I primary hyperoxaluria, and some alter subcellular targeting of the protein. Mouse and rat each have an orthologous Agxt gene. Check the datasheet of any product for its validated reactivity.
Other transaminases, glyoxylate-metabolism enzymes and peroxisomal proteins studied alongside AGXT.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21549; product specifications from Assay Genie datasheets.